Table 3.
SS patients and controls' drugs.
| Drugs | SS | Controls | Test | p Value |
|---|---|---|---|---|
| Opioids | 2 (2.8 %) | 0 | Fisher exact test | 0.248 |
| Antidepressants | 3 (4.2%) | 2 (2.8%) | Fisher exact test | 0.5 |
| Anti-diabetic drugs | 4 (5.6%) | 4 (5.6%) | Fisher exact test | 0.641 |
| Antihypertensives | 26 (36.1%) | 16 (22.2%) | Fisher exact test | 0.049 |
| Acetylsalicylic acid | 9 (12.5%) | 3 (4.2%) | Χ2 = 3.273 | 0.071 |
| benzodiazepines | 4 (5.6%) | 0 | Fisher exact test | 0.059 |
| Bisphosphonates | 10 (13.9%) | 1 (1.4%) | Χ2 = 7.973 | 0.005 |
| Cholecalciferol | 57 (79.2%) | 4 (5.6%) | Χ2 = 79.893 | < 0,001 |
| Corticosteroids | 50 (69.4%) | 0 | Χ2 = 76.596 | < 0.001 |
| Nonsteroidal anti-Inflammatory drugs | 6 (8.3%) | 1 (1.4%) | Fisher exact test | 0.057 |
| Biotechnological drugs | 8 (11.1%) | 0 | Fisher exact test | 0.003 |
| Hydroxychloroquine | 29 (40.3%) | 0 | Χ2 = 36.313 | < 0.001 |
| Immunosuppressing drugs | 1 (1,4%) | 0 | Fisher exact test | 0.5 |
| Antacids | 44 (61.1 %) | 3 (4.2%) | Χ2 = 53.096 | < 0.001 |
| Levothyroxine | 15 (20.8%) | 8 (11.1%) | Χ2 = 2.535 | 0.112 |
| Methotrexate | 23 (31.9%) | 0 | Χ2 = 27.372 | < 0.001 |
| Muscle relaxants | 11 (15.3%) | 0 | Χ2 = 11.909 | < 0.001 |
| Pilocarpine | 21 (29.2%) | 0 | Χ2 = 24.585 | < 0.001 |
| Statins and fibrates | 7 (9.7%) | 4 (5.6%) | Χ2 = 0.886 | 0.347 |
| Sulfasalazine | 3 (4.2%) | 0 | Fisher exact test | 0.123 |
| Topical treatment | 36 (50.0%) | 0 | Χ2 = 48.00 | < 0.001 |